http://www.twitter.comTwitter is a service for friends, family, and co-workers to communicate and stay connected through the exchange of quick, frequent answers to one simple question: What are you doing?
-
Evofem Biosciences Files Preliminary Proxy for Stockholder Approval of the Acquisition by Aditxt
-
Aditxt’s Subsidiary Pearsanta to Collaborate with Evofem Biosciences for Targeted U.S. Launch of Endometriosis Diagnostic in Mid-2025
-
Aditxt and Evofem Sign Second Amendment to Amended and Restated Merger Agreement, Target Closing of Acquisition in Fourth Quarter of 2024
-
Evofem Biosciences (EVFM) Addresses the Impact of GLP-1 Medications on Oral Contraceptive Absorption and Introduces Phexxi as a Non-Oral Solution
-
Evofem Biosciences Addresses the Impact of GLP-1 Medications on Oral Contraceptive Absorption and Introduces Phexxi as a Non-Oral Solution
-
Evofem Biosciences Announces Financial Results for the Second Quarter of 2024
-
Evofem Biosciences to Present at the OTCQB Venture Virtual Investor Conference on August 1st
-
Evofem Signs Phexxi® License Agreement for Middle East with Pharma 1
-
Lupin Divests U.S. Commercial Women's Health Specialty Business to Evofem, including SOLOSEC
-
Aditx Therapeutics (ADTX) to Acquire 50% Stake in Global Response Aid
-
Aditxt Signs Asset Purchase Agreement to Acquire Fifty Percent Ownership of Global Response Aid – with Rights to Manufacture and Market Broad-Spectrum Antiviral Drug Avigan
